Gefitinib D8

Modify Date: 2024-01-19 08:48:18

Gefitinib D8 Structure
Gefitinib D8 structure
Common Name Gefitinib D8
CAS Number 857091-32-8 Molecular Weight 454.95200
Density N/A Boiling Point N/A
Molecular Formula C22H16D8ClFN4O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Gefitinib D8


Gefitinib D8 (ZD1839 D8) is a deuterium labeled Gefitinib. Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells[1][2].

 Names

Name N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(2,2,3,3,5,5,6,6-octadeuteriomorpholin-4-yl)propoxy]quinazolin-4-amine

 Gefitinib D8 Biological Activity

Description Gefitinib D8 (ZD1839 D8) is a deuterium labeled Gefitinib. Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells[1][2].
Related Catalog
Target

IC50: 37 nM (Tyr1173 site, in NR6wtEGFR cells), 37 nM (Tyr992 site, in NR6wtEGFR cells)[1]

References

[1]. Pedersen MW, et al. Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII. Br J Cancer. 2005 Oct 17;93(8):915-23.

[2]. Moasser MM, et al. The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells. Cancer Res. 2001 Oct 1;61(19):7184-8.

 Chemical & Physical Properties

Molecular Formula C22H16D8ClFN4O3
Molecular Weight 454.95200
Exact Mass 454.20200
PSA 68.74000
LogP 4.28650